Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

De-Identified Health Data Market Value Analysis: What Growth Is Expected Over The Forecast Period?

The de-identified health data market has experienced substantial expansion recently, with projections indicating continued growth from $9.2 billion in 2025 to $10.31 billion in 2026, reflecting a compound annual growth rate of 12.1%. This upward trajectory during the historical period is largely driven by several key factors including a heightened embrace of electronic health records, an escalating need for population health analytics, the broadening scope of clinical research databases, a heightened emphasis on adhering to patient privacy regulations, and a greater availability of organized healthcare data.

The market for de-identified health data is poised for substantial expansion, projecting a reach of $16.07 billion by 2030, reflecting an 11.7% compound annual growth rate. This upward trajectory is fueled by several key factors, including the increasing utilization of artificial intelligence for health insights, augmented investments in precision medicine research, the broadening application of value-based care analytics, a heightened need for secure health data exchange mechanisms, and a greater reliance on real-world evidence in regulatory processes. During this forecast period, prominent trends include the development of extensive de-identified data platforms, a surge in real-world evidence analytics, greater demand for data sharing models that prioritize privacy, enhanced adoption of longitudinal patient data analysis, and the integration of healthcare datasets from diverse sources.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28191&type=smp

#De-Identified Health Data Market Demand Drivers Creating New Revenue Opportunities

The expansion of the de-identified health data market is poised for acceleration, primarily fueled by the widespread integration of electronic health records (EHRs). These digital repositories, essentially comprehensive digital chronicles of a patient’s medical journey encompassing diagnoses, treatments, prescriptions, laboratory findings, and other vital health details, are designed for secure storage and dissemination among authorized medical practitioners. The escalating utilization of EHRs stems from their demonstrated capacity to elevate the quality and security of patient care by providing immediate access to thorough medical histories. De-identified health data, by facilitating secure information exchange and sophisticated analytical capabilities without compromising patient confidentiality, further augments EHR systems. This, in turn, contributes to more informed clinical judgments and superior health system results. As an illustration, data from the U.S. National Institutes of Health’s National Center for Biotechnology Information, published in 2024, indicated that by August 2025, a significant majority of hospitals had implemented patient engagement tools allowing individuals to electronically view (99%), download (96%), and transfer their health information (84%) to external entities. Consequently, the growing prevalence of EHR implementation is a key driver for the de-identified health data market’s growth.

De-Identified Health Data Market Segment Performance And Strategic Opportunities

The de-identified health data market covered in this report is segmented –

1) By Type: Clinical Data, Genomic Data, Patient Demographics, Prescription Data, Hospital And Provider Data, Pharmacogenomic Data

2) By Application: Clinical Research And Trials, Public Health, Precision Medicine, Health Economics And Outcomes Research (HEOR), Population Health Management, Drug Discovery And Development, Healthcare Quality Improvement, Insurance Underwriting And Risk Assessment, Other Applications

3) By End-User: Pharmaceutical Companies, Biotechnology Firms, Healthcare Providers, Insurance Companies Or Healthcare Payers, Research Institutions, Government Agencies, Other End-Users

Subsegments:

1) By Clinical Data: Electronic Health Records, Medical Imaging Data, Laboratory Test Results, Surgical Reports, Pathology Reports, Vital Signs Measurements

2) By Genomic Data: Whole Genome Sequencing Data, Exome Sequencing Data, Single Nucleotide Polymorphism Data, Gene Expression Profiles, Epigenetic Data

3) By Patient Demographics: Age Information, Gender Information, Ethnicity Information, Geographic Location, Socioeconomic Status, Marital Status

4) By Prescription Data: Medication Orders, Dosage Information, Prescription Refill History, Drug Allergies, Pharmacy Dispensation Records

5) By Hospital And Provider Data: Provider Performance Metrics, Care Delivery Outcomes, Billing And Claims Data, Resource Utilization Data

6) By Pharmacogenomic Data: Gene–Drug Interaction Data, Adverse Drug Reaction Data, Personalized Therapy Response Data, Drug Efficacy Variation Data

De-Identified Health Data Market Trends Driving Strategic Industry Expansion

Leading entities within the de-identified health data sector are prioritizing the creation of sophisticated offerings, including applications for real-world biomarker coverage, aimed at bolstering evidence-based medical choices. Such an application utilizes anonymized patient information to observe and evaluate biomarker trends and their efficacy across varied demographics beyond the confines of clinical studies, thereby equipping researchers and medical professionals with deeper understanding of treatment outcomes and prevalent disease trajectories. Illustratively, in July of 2025, Datma Inc., a health technology firm headquartered in the United States, introduced the Federated Biomarker Explorer, a utility accessible at no cost to pharmaceutical groups, facilitating rapid confirmation of real-world biomarker coverage throughout Datma’s distributed network of contributing data sources. This instrument furnishes summarized, group-level data regarding biomarker prevalence, permitting swift coverage evaluations without necessitating formal agreements or information technology assistance. Furthermore, it permits the secure incorporation of proprietary datasets for comparative analysis and supports preliminary viability assessments through the application of clinical and demographic filters, assisting in the determination of whether available datasets encompass the requisite patient demographics prior to resource commitment.

De-Identified Health Data Market Key Players: Which Companies Shape Industry Competition?

Major companies operating in the de-identified health data market are UnitedHealth Group Incorporated, Oracle Corporation, IQVIA Holdings Inc, ICON Public Limited Company, Datavant Inc, Premier Inc., iMerit Technology Services Pvt. Ltd., Tempus Labs Inc., Medidata Solutions Inc., Veradigm Inc., Flatiron Health, Merative LP, Komodo Health Inc., Shaip Inc., Truveta Inc., Evidation Health Inc., TriNetX Inc., Clarify Health Solutions Inc., Akrivia Health Ltd., Gradient Health Inc.

Access The Complete De-Identified Health Data Market Report:

https://www.thebusinessresearchcompany.com/report/de-identified-health-data-global-market-report

De-Identified Health Data Market Geographic Analysis: Where Is Demand Growing The Fastest?

North Americawas the largest region in the de-identified health data market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the de-identified health data market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model